Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study: ICC case series

Dutch Initiative on Crohn and Colitis; G Dijkstra

Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study: ICC case series

Dutch Initiative on Crohn and Colitis
, G Dijkstra

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	S405
Aantal pagina's	1
Tijdschrift	Journal of Crohn's and Colitis
Volume	12
Status	Published - feb-2018

Handle.net

Permanente koppeling

Parel Infammatory Bowel Disease (IBD)
Dijkstra, G. (Creator), F.M., T. (Other), Lowenberg, M. (Creator), Bosma, C. (Data Manager) & Terpstra, F. (Data Manager), University of Groningen, 2017
https://1000ibd.org/menu/main/background
Dataset

Citeer dit

@article{250256c580fd4196942153cd9fde7253,

title = "Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study: ICC case series",

author = "\{Dutch Initiative on Crohn and Colitis\} and V. Biemans and \{van der Woude\}, C. and \{van der Meulen-de Jong\}, A. and B. Oldenburg and \{de Boer\}, N. and C. Ponsioen and \{de Vries\}, A. and J. Haans and M. Pierik and F. Hoentjen and G Dijkstra",

year = "2018",

month = feb,

language = "English",

volume = "12",

pages = "S405",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study

T2 - ICC case series

AU - Dutch Initiative on Crohn and Colitis

AU - Biemans, V.

AU - van der Woude, C.

AU - van der Meulen-de Jong, A.

AU - Oldenburg, B.

AU - de Boer, N.

AU - Ponsioen, C.

AU - de Vries, A.

AU - Haans, J.

AU - Pierik, M.

AU - Hoentjen, F.

AU - Dijkstra, G

PY - 2018/2

Y1 - 2018/2

M3 - Meeting Abstract

SN - 1873-9946

VL - 12

SP - S405

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

ER -

Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study: ICC case series

Handle.net

Datasets

Parel Infammatory Bowel Disease (IBD)

Citeer dit